Literature DB >> 2567676

The effects of anti-CD2 antibodies on the differentiation of mouse thymocytes.

B A Kyewski1, E J Jenkinson, R Kingston, P Altevogt, M J Owen, J J Owen.   

Abstract

Using a rat monoclonal antibody against mouse CD2, we determined the expression of this marker on thymocytes during ontogeny. CD2 expression becomes detectable at day 15 and reaches adult levels (approximately 95% positivity) by day 19. Furthermore, the effect of anti-CD2 antibodies on T cell differentiation was analyzed by addition of antibodies to thymus organ cultures or repeated injection into newborn mice. Anti-CD2 antibodies inhibit CD2 expression in organ cultures and drastically reduce its expression on thymocytes and peripheral lymphocytes in vivo. In either situation, suppression of CD2 expression does not significantly alter the generation of T cells expressing CD3, CD4, CD8 and T cell receptor V beta 8. These results do not support a role for CD2 in early steps of thymocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567676     DOI: 10.1002/eji.1830190526

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  11 in total

1.  Defective signal transduction by the CD2 molecule in immature T-cell receptor/CD3- thymocytes.

Authors:  L A Turka; M C Fletcher; N Craighead; C B Thompson; C H June
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

3.  The organotin-induced thymus atrophy, characterized by depletion of CD4+ CD8+ thymocytes, is preceded by a reduction of the immature CD4- CD8+ TcR alpha beta-/low CD2high thymoblast subset.

Authors:  R H Pieters; M Bol; B W Lam; W Seinen; A H Penninks
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

4.  Recovery from chemically induced thymus atrophy starts with CD4- CD8- CD2high TcR alpha beta-/low thymocytes and results in an increased formation of CD4- CD8- TcR alpha beta high thymocytes.

Authors:  R H Pieters; M Bol; B W Lam; W Seinen; N Bloksma; A H Penninks
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

5.  Anti-CD11a prevents deletion of self-reactive T cells in neonatal C57BR mice.

Authors:  J Quddus; A Kaplan; B C Richardson
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

6.  Proliferation of an athymic mouse-derived T-cell clone on thymic stromal cells with interleukin-2.

Authors:  H Tamura; H Kuzuhara; C Hiramine; K Hojo; H Yamamoto; S Fujimoto
Journal:  Immunology       Date:  1991-10       Impact factor: 7.397

7.  Anti-CD2 antibodies induce T cell unresponsiveness in vivo.

Authors:  B Gückel; C Berek; M Lutz; P Altevogt; V Schirrmacher; B A Kyewski
Journal:  J Exp Med       Date:  1991-11-01       Impact factor: 14.307

8.  Development and function of T cells in mice with a disrupted CD2 gene.

Authors:  N Killeen; S G Stuart; D R Littman
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment.

Authors:  B F Haynes; C S Heinly
Journal:  J Exp Med       Date:  1995-04-01       Impact factor: 14.307

10.  A threshold level of NFATc1 activity facilitates thymocyte differentiation and opposes notch-driven leukaemia development.

Authors:  Stefan Klein-Hessling; Ronald Rudolf; Khalid Muhammad; Klaus-Peter Knobeloch; Muhammad Ahmad Maqbool; Pierre Cauchy; Jean-Christophe Andrau; Andris Avots; Claudio Talora; Volker Ellenrieder; Isabella Screpanti; Edgar Serfling; Amiya Kumar Patra
Journal:  Nat Commun       Date:  2016-06-17       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.